Researchers probe how arthritis drugs affect COVID-19 immunity
NCT ID NCT04584541
Summary
This study aimed to understand how immunosuppressive drugs used for rheumatoid arthritis and spondyloarthritis affect the body's response to COVID-19. Researchers compared 150 patients taking these medications with infected family members not on such drugs. The goal was to measure differences in viral shedding and antibody production to inform future treatment and vaccination strategies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cochin hospital
Paris, 75014, France
Conditions
Explore the condition pages connected to this study.